Indeed, it has been reported that aberrant expression of CD39 and CD73 in circulating or skin-homing CD4+ T cells of SS patients can affect the metabolism of ATP as well as the production of ADO, thus impacting immune responses [92]. This evidence concerns the gene CD4 and synovial sarcoma.